These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 17766714
21. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats. Livingstone DE, Walker BR. J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365 [Abstract] [Full Text] [Related]
22. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, Courtney R, Rejto P, Carley W, Stewart PM. J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165 [Abstract] [Full Text] [Related]
23. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R, Wood PJ, Banerjee AK, Holder G, Barnett AH, Stewart PM, Kumar S. J Clin Endocrinol Metab; 2004 Sep; 89(9):4755-61. PubMed ID: 15356090 [Abstract] [Full Text] [Related]
24. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women. Rask E, Simonyte K, Lönn L, Axelson M. Clin Endocrinol (Oxf); 2013 May; 78(5):700-5. PubMed ID: 22233384 [Abstract] [Full Text] [Related]
25. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, Strasburger CJ, Stewart PM, Quinkler M. Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910 [Abstract] [Full Text] [Related]
26. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. Mariniello B, Ronconi V, Rilli S, Bernante P, Boscaro M, Mantero F, Giacchetti G. Eur J Endocrinol; 2006 Sep; 155(3):435-41. PubMed ID: 16914598 [Abstract] [Full Text] [Related]
27. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children. Zhu L, Hou M, Sun B, Burén J, Zhang L, Yi J, Hernell O, Li X. J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225 [Abstract] [Full Text] [Related]
28. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE. Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348 [Abstract] [Full Text] [Related]
38. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Palermo M, Shackleton CH, Mantero F, Stewart PM. Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758 [Abstract] [Full Text] [Related]
39. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice. Park SB, Jung WH, Kang NS, Park JS, Bae GH, Kim HY, Rhee SD, Kang SK, Ahn JH, Jeong HG, Kim KY. Eur J Pharmacol; 2013 Dec 05; 721(1-3):70-9. PubMed ID: 24135201 [Abstract] [Full Text] [Related]